期刊發表

類別
日期
癌症相關
非臨床研究
傳輸技術
2009-12
Therapeutic efficacy evaluation of 111In-labeled PEGylated liposomal vinorelbine in murine colon carcinoma with multimodalities of molecular imaging.
作者 Chow, T. H., Lin, Y. Y., Hwang, J. J., Wang, H. E., Tseng, Y. L., Pang, V. F., Liu, R. S., Lin, W. J., Yang, C. S., and Ting, G.
已發表 Nucl. Med.,
50:2073-2081, 2009.
癌症相關
非臨床研究
傳輸技術
2009-08
Evaluation of pharmacokinetics of 111In-labeled VNB-PEGylated liposomes after intraperitoneal and intravenous administration in a tumor/ascites mouse model.
作者 Lin, Y. Y., Li, J. J., Chang, C. H., Lu, Y. C., Hwang, J. J., Tseng, Y. L., Lin, W. J., Ting, G., and Wang, H. E.
已發表 Cancer Biother Radiopharm.,
24:453-460, 2009.
癌症相關
傳輸技術
2009-01
Improved pharmacokinetics and efficacy of a highly stable nanoliposomal vinorelbine.
作者 Drummond DC, Noble CO, Guo Z, Hayes ME, Park JW, Ou CJ, Tseng YL, Hong K, Kirpotin DB.
已發表 J Pharmacol Exp Ther.
328(1):321-30.
癌症相關
非臨床研究
傳輸技術
2008-07
Diagnostic and therapeutic evaluation of 111In-vinorelbine-liposomes in a human colorectal carcinoma HT-29/luc-bearing animal model.
作者 Chow, T. H., Lin, Y. Y., Hwang, J. J., Wang, H. E., Tseng, Y. L., Pang, V. F., Wang, S. J., Whang-Peng, J., and Ting, G.
已發表 Nucl.Med.Biol., 35:623-634, 2008.
癌症相關
新藥研發
2007-02
Monitoring and quantitative assessment of tumor burden using in vivo bioluminescence imaging.
作者 Chen, C.C., Hwang, J.J., Ting, G., Tseng, Y.L., Wang, S.J. and Whang-Peng, J.
已發表 Nuclear Instruments and Methods in Physics Research A, 571:437-441, 2007.
癌症相關
非臨床研究
傳輸技術
2006-12
Therapeutic efficacy evaluation of 111in-VNB-liposome on human colorectal adenocarcinoma HT-29/luc mouse xenografts.
作者 Lee, W.C., Hwang, J.J., Tseng, Y.L., Wang, H.E., Chang, Y.F., Lu, Y.C., Ting, G., Whang-Peng, J. and Wang, S.J.
已發表 Nuclear Instruments and Methods in Physics Research A, 569:497-504, 2006.
癌症相關
傳輸技術
2006-03
Development of a highly active nanoliposomal irinotecan using a novel intraliposomal stabilization strategy.
作者 Drummond DC, Noble CO, Guo Z, Hong K, Park JW, Kirpotin DB.
已發表 Cancer Res.
66(6):3271-7
癌症相關
臨床研究
2003-03
A phase II and pharmacokinetic study of pegylated liposomal doxorubicin in patients with advanced hepatocellular carcinoma.
作者 Hong, R.L. and Tseng, Y.L.
已發表 Cancer Chemotherapy & Pharmacology., 51:433-438, 2003.
癌症相關
臨床研究
2001-04
Phase I and pharmacokinetic study of a stable, polyethylene-glycolated liposomal doxorubicin in patients with solid tumors: the relation between pharmacokinetic property and toxicity.
作者 Hong, R.L. and Tseng, Y.L.
已發表 Cancer, 91:1826-1833, 2001.
癌症相關
臨床研究
2000-03
Pegylated liposomal doxorubicin in treating a case of advanced hepatocellular carcinoma with severe hepatic dysfunction and pharmacokinetic study.
作者 Hong, R.L., Tseng, Y.L., Chang, F.H.
已發表 Ann Oncol, 11:349-353, 2000.
of
3
您即將離開TLC網站

您將前往外部網站，該網站之內容及其維護等將由第三方對其負全部責任。

TLC僅提供此連結予您參考， TLC不對任何第三方網站之隱私政策負責。我們提醒您詳讀您造訪之各網站的隱私政策。

點擊"停留"或右上角關閉視窗以留在此網站，或點擊"繼續"

繼續 停留